AMMONIUM CHLORIDE

AMMONIUM CHLORIDE was reported 250 times

AMMONIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 81 0.4091
1 ANTACID THERAPY 52 0.4000
2 ANALGESIC THERAPY 81 0.2523
3 CONGENITAL HIATUS HERNIA 55 0.2412
4 APPENDICOLITH 92 0.2377
5 DRUG THERAPY 79 0.2330
6 MALIGNANT MELANOMA STAGE 0 45 0.2153
7 ANTICOAGULANT THERAPY 52 0.1831
8 BACTEROIDES INFECTION 29 0.1111
9 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 48 0.0518
10 HYPERPHOSPHATAEMIA 94 0.0437
11 BLOOD PHOSPHORUS INCREASED 85 0.0311
12 TOTAL LUNG CAPACITY DECREASED 35 0.0219
13 VASCULAR ACCESS SITE THROMBOSIS 1 0.0200
14 VAGINAL FLATULENCE 6 0.0198
15 PLEURITIC PAIN 43 0.0156
16 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 78 0.0154
17 RESPIRATORY SYMPTOM 41 0.0144
18 IRON DEFICIENCY 63 0.0140
19 HYPOPHOSPHATAEMIA 102 0.0138
20 BLOOD URIC ACID INCREASED 78 0.0135
21 FEEDING PROBLEM IN NEWBORN 1 0.0132
22 MYASTHENIA GRAVIS 106 0.0131
23 LUNG OPACITY 34 0.0129
24 AORTIC STENOSIS 39 0.0112
25 VASCULAR ACCESS SITE INFECTION 1 0.0104
26 APPENDICITIS 93 0.0099
27 BREATH SOUNDS ABNORMAL 45 0.0091
28 BENIGN PROSTATIC HYPERPLASIA 47 0.0091
29 MICROEMBOLISM 1 0.0088
30 TROPONIN INCREASED 65 0.0085
31 VENTRICULAR FIBRILLATION 93 0.0084
32 LARYNGITIS FUNGAL 1 0.0078
33 BLOOD CALCIUM INCREASED 62 0.0071
34 CARDIOGENIC SHOCK 89 0.0062
35 BACTERIAL INFECTION 104 0.0056
36 HYPERLIPIDAEMIA 66 0.0055
37 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 92 0.0054
38 HYPERCHOLESTEROLAEMIA 47 0.0049
39 NEURALGIA 109 0.0045
40 ULCER 71 0.0045
41 BLOOD TEST ABNORMAL 62 0.0044
42 ASPIRATION 48 0.0044
43 OLIGODIPSIA 1 0.0043
44 MULTIPLE ORGAN DYSFUNCTION SYNDROME 117 0.0041
45 FULL BLOOD COUNT ABNORMAL 43 0.0041
46 DRUG LABEL CONFUSION 1 0.0040
47 GOUT 70 0.0039
48 CHILD ABUSE 1 0.0039
49 MICTURITION URGENCY 44 0.0038
50 END STAGE RENAL DISEASE 68 0.0037
51 RED BLOOD CELL SEDIMENTATION RATE 1 0.0036
52 FEMALE GENITAL TRACT FISTULA 6 0.0035
53 ASCITES 94 0.0032
54 ADNEXAL TORSION 1 0.0032
55 INFUSION 1 0.0024
56 RALES 14 0.0024
57 RADICULOPATHY 6 0.0023
58 JOINT INJURY 47 0.0022
59 RHONCHI 3 0.0022
60 PROCTITIS 6 0.0021
61 HYPONATRAEMIA 118 0.0021
62 BRONCHIECTASIS 14 0.0021
63 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 106 0.0020
64 TRANSAMINASES INCREASED 45 0.0020
65 SPUTUM DISCOLOURED 17 0.0018
66 BLOOD CHOLESTEROL INCREASED 81 0.0017
67 SJOGREN'S SYNDROME 1 0.0017
68 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
69 CARDIOVASCULAR DISORDER 41 0.0016
70 PSOAS ABSCESS 1 0.0016
71 CHRONIC SINUSITIS 6 0.0016
72 OEDEMA GENITAL 1 0.0016
73 BICYTOPENIA 3 0.0015
74 CORONARY ARTERY DISEASE 46 0.0015
75 IRON DEFICIENCY ANAEMIA 14 0.0015
76 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 1 0.0015
77 SLEEP DISORDER 104 0.0015
78 LOWER RESPIRATORY TRACT INFECTION 66 0.0014
79 DIABETES MELLITUS 110 0.0014
80 EYE ROLLING 1 0.0014
81 INVESTIGATION ABNORMAL 2 0.0014
82 OVARIAN MASS 1 0.0014
83 BLOOD PARATHYROID HORMONE DECREASED 2 0.0013
84 THROMBOSIS 108 0.0013
85 ENTHESOPATHY 2 0.0013
86 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
87 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
88 PNEUMONIA MYCOPLASMAL 1 0.0013
89 HAEMOPERITONEUM 1 0.0012
90 SWELLING 116 0.0012
91 LIVER FUNCTION TEST INCREASED 26 0.0012
92 INTENTIONAL PRODUCT MISUSE 106 0.0012
93 MEAN PLATELET VOLUME DECREASED 1 0.0012
94 DRY MOUTH 91 0.0011
95 DRUG INTOLERANCE 107 0.0011
96 GENERAL PHYSICAL HEALTH DETERIORATION 126 0.0011
97 PULMONARY EMBOLISM 103 0.0011
98 SEPSIS 118 0.0011
99 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
100 BLOOD CREATININE INCREASED 65 0.0010
101 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
102 PULMONARY MASS 14 0.0009
103 ABDOMINAL DISTENSION 97 0.0009
104 HYPOVENTILATION 3 0.0009
105 PRODUCT NAME CONFUSION 1 0.0009
106 PROSTATE CANCER METASTATIC 3 0.0009
107 HALO VISION 1 0.0009
108 HYPOPNOEA 3 0.0009
109 LIVER DISORDER 38 0.0009
110 FEBRILE INFECTION 1 0.0008
111 PANNICULITIS 2 0.0008
112 MUSCULOSKELETAL STIFFNESS 71 0.0008
113 MALIGNANT MELANOMA IN SITU 1 0.0008
114 LUNG DISORDER 39 0.0008
115 LUPUS VULGARIS 1 0.0008
116 PULMONARY FIBROSIS 15 0.0008
117 INCISIONAL HERNIA 1 0.0007
118 HAEMOPTYSIS 20 0.0007
119 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
120 SEBORRHOEIC KERATOSIS 1 0.0007
121 URINARY TRACT DISORDER 3 0.0007
122 PLEURAL EFFUSION 40 0.0007
123 UMBILICAL HERNIA 3 0.0006
124 ACUTE LEUKAEMIA 1 0.0006
125 SOMNOLENCE 122 0.0006
126 VAGINAL DISCHARGE 6 0.0006
127 ANAEMIA 113 0.0006
128 RETINITIS 1 0.0006
129 GRANULOMA 2 0.0006
130 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
131 LYMPH NODE PAIN 1 0.0005
132 OEDEMA PERIPHERAL 65 0.0005
133 MACULAR DEGENERATION 6 0.0005
134 GASTROINTESTINAL DISORDER 45 0.0005
135 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
136 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
137 ASTHMA 52 0.0005
138 RENAL TUBULAR ACIDOSIS 1 0.0005
139 POLYP 3 0.0005
140 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
141 ORAL CANDIDIASIS 6 0.0005
142 RESPIRATORY RATE INCREASED 4 0.0005
143 CONSTIPATION 97 0.0004
144 SUSPECTED OFF LABEL USE 2 0.0004
145 ABDOMINAL PAIN 100 0.0004
146 CONDITION AGGRAVATED 130 0.0004
147 OXYGEN CONSUMPTION INCREASED 1 0.0004
148 PARAESTHESIA ORAL 6 0.0004
149 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
150 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
151 CATHETER SITE HAEMORRHAGE 1 0.0004
152 HELICOBACTER INFECTION 4 0.0004
153 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
154 HYPOXIA 13 0.0004
155 HYPERTENSION 77 0.0004
156 RHEUMATOID NODULE 1 0.0004
157 TENOSYNOVITIS 1 0.0004
158 DRUG TOLERANCE DECREASED 1 0.0004
159 SKIN HYPERTROPHY 1 0.0004
160 INFUSION SITE REACTION 1 0.0003
161 RESPIRATORY RATE DECREASED 1 0.0003
162 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
163 SWOLLEN JOINT COUNT INCREASED 1 0.0003
164 HYPERREFLEXIA 1 0.0003
165 BONE EROSION 1 0.0003
166 PRODUCT USE IN UNAPPROVED INDICATION 70 0.0003
167 FEAR OF INJECTION 2 0.0003
168 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
169 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
170 TREMOR 44 0.0003
171 AZOTAEMIA 1 0.0003
172 DERMATITIS ALLERGIC 3 0.0002
173 TENSION HEADACHE 1 0.0002
174 BLOOD CREATINE INCREASED 1 0.0002
175 RHEUMATIC FEVER 1 0.0002
176 FREQUENT BOWEL MOVEMENTS 6 0.0002
177 SYNOVITIS 4 0.0002
178 WHEEZING 13 0.0002
179 INCREASED TENDENCY TO BRUISE 2 0.0002
180 PROCEDURAL PAIN 6 0.0002
181 PERFORMANCE STATUS DECREASED 1 0.0002
182 VOMITING 100 0.0002
183 INFUSION RELATED REACTION 14 0.0002
184 DRUG TOLERANCE 1 0.0002
185 BODY TEMPERATURE INCREASED 4 0.0002
186 SKIN NECROSIS 1 0.0002
187 FAILURE TO THRIVE 1 0.0002
188 PARTIAL SEIZURES 1 0.0002
189 SUDDEN DEATH 2 0.0002
190 RESPIRATORY TRACT CONGESTION 3 0.0002
191 NYSTAGMUS 1 0.0002
192 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
193 METASTASES TO BONE 3 0.0002
194 DEAFNESS UNILATERAL 1 0.0002
195 RHEUMATOID FACTOR POSITIVE 1 0.0002
196 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 31 0.0002
197 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
198 BLOOD IRON DECREASED 2 0.0002
199 PRODUCT DOSE OMISSION ISSUE 49 0.0002
200 TYPE 1 DIABETES MELLITUS 1 0.0002
201 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
202 C-REACTIVE PROTEIN INCREASED 6 0.0002
203 PYREXIA 57 0.0002
204 FIBROMYALGIA 4 0.0002
205 CYTOPENIA 2 0.0002
206 HYPERCALCAEMIA 2 0.0002
207 BLEPHAROSPASM 1 0.0002
208 COLITIS 6 0.0002
209 COLITIS ULCERATIVE 7 0.0002
210 HEPATITIS 4 0.0002
211 BREAST CANCER STAGE III 1 0.0002
212 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
213 MENINGITIS 1 0.0001
214 OFF LABEL USE 130 0.0001
215 DYSPNOEA 84 0.0001
216 ULCER HAEMORRHAGE 1 0.0001
217 ONYCHOCLASIS 1 0.0001
218 RIGHT VENTRICULAR FAILURE 1 0.0001
219 RECTAL HAEMORRHAGE 6 0.0001
220 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
221 TONGUE DISORDER 1 0.0001
222 ASTHENIA 51 0.0001
223 BLINDNESS TRANSIENT 1 0.0001
224 CEREBRAL DISORDER 1 0.0001
225 DUODENAL ULCER PERFORATION 1 0.0001
226 HEART RATE IRREGULAR 3 0.0001
227 DRUG DISPENSING ERROR 2 0.0001
228 NAUSEA 103 0.0001
229 BASAL CELL CARCINOMA 2 0.0001
230 TORSADE DE POINTES 1 0.0001
231 MUSCLE INJURY 1 0.0001
232 PNEUMONIA 39 0.0001
233 LIVE BIRTH 1 0.0001
234 TYPE 2 DIABETES MELLITUS 4 0.0001
235 INFUSION SITE ERYTHEMA 1 0.0001
236 HAEMATOMA 3 0.0001
237 SKIN SWELLING 1 0.0001
238 RESPIRATORY TRACT INFECTION 3 0.0001
239 GRIP STRENGTH DECREASED 1 0.0001
240 DRUG ERUPTION 2 0.0001
241 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
242 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
243 OSTEOMYELITIS 2 0.0001
244 LUPUS-LIKE SYNDROME 1 0.0001
245 EXOSTOSIS 1 0.0001
246 HAEMATOCHEZIA 6 0.0001
247 ARTERIOSCLEROSIS 1 0.0001
248 MUSCULOSKELETAL DISORDER 2 0.0001
249 THROMBOTIC MICROANGIOPATHY 1 0.0001
250 AUTOIMMUNE DISORDER 1 0.0001
251 BODY TEMPERATURE DECREASED 1 0.0001
252 RESPIRATORY DISORDER 3 0.0001
253 SLUGGISHNESS 1 0.0001
254 POOR VENOUS ACCESS 1 0.0001
255 PAIN 59 0.0001
256 WEIGHT FLUCTUATION 1 0.0001
257 FOLLICULITIS 1 0.0001
258 INJECTION SITE DISCOMFORT 1 0.0001
259 JOINT DISLOCATION 1 0.0001
260 OSTEOARTHRITIS 4 0.0001
261 HEADACHE 59 0.0001
262 PHARYNGITIS STREPTOCOCCAL 1 0.0001
263 PULMONARY THROMBOSIS 1 0.0001
264 FOOT DEFORMITY 1 0.0001
265 SKIN INFECTION 1 0.0001
266 BLOOD CALCIUM DECREASED 1 0.0001
267 GASTRIC HAEMORRHAGE 1 0.0001
268 HYPERKALAEMIA 3 0.0001
269 COVID-19 PNEUMONIA 1 0.0001
270 PRODUCTIVE COUGH 4 0.0001
271 MOBILITY DECREASED 6 0.0001
272 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
273 ABDOMINAL PAIN UPPER 17 0.0001
274 INJECTION SITE DISCOLOURATION 1 0.0001
275 PEMPHIGUS 1 0.0001
276 BRAIN OEDEMA 1 0.0001
277 INJECTION SITE IRRITATION 1 0.0001
278 INFUSION SITE PAIN 1 0.0001
279 INFLAMMATION 4 0.0001
280 SKIN ULCER 2 0.0001
281 FATIGUE 60 0.0001
282 PLATELET COUNT INCREASED 1 0.0001
283 HAND DEFORMITY 1 0.0001
284 IMMUNE SYSTEM DISORDER 1 0.0001
285 SARS-COV-2 TEST POSITIVE 1 0.0001
286 MALIGNANT MELANOMA 1 0.0001
287 JOINT RANGE OF MOTION DECREASED 1 0.0001
288 DISTURBANCE IN ATTENTION 4 0.0001
289 TACHYPNOEA 1 0.0001
290 DRUG TOXICITY 1 0.0001
291 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
292 COORDINATION ABNORMAL 1 0.0001
293 DYSPEPSIA 7 0.0001
294 SEASONAL ALLERGY 1 0.0001
295 SINUSITIS 7 0.0001
296 COUGH 19 0.0001
297 DRUG INEFFECTIVE 88 0.0001
298 BLOOD COUNT ABNORMAL 1 0.0001
299 EPILEPSY 2 0.0001
300 HIP ARTHROPLASTY 1 0.0001
301 TENDONITIS 1 0.0001
302 LUNG INFECTION 1 0.0001
303 DRUG-INDUCED LIVER INJURY 2 0.0001
304 METABOLIC ACIDOSIS 2 0.0001
305 BLOOD POTASSIUM INCREASED 1 0.0001
306 VENTRICULAR TACHYCARDIA 1 0.0001
307 PHOTOSENSITIVITY REACTION 1 0.0001
308 TREATMENT FAILURE 5 0.0001
309 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
310 ABDOMINAL DISCOMFORT 10 0.0001
311 PERICARDITIS 1 0.0001
312 FACE OEDEMA 1 0.0001
313 HEPATIC ENZYME INCREASED 4 0.0001
314 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
315 ARTHROPATHY 3 0.0001
316 MEDICATION ERROR 3 0.0001
317 HEPATIC CIRRHOSIS 1 0.0001
318 INTESTINAL OBSTRUCTION 2 0.0001
319 PROTEINURIA 1 0.0001
320 LOWER LIMB FRACTURE 1 0.0001
321 PRESCRIBED OVERDOSE 1 0.0001
322 EAR PAIN 1 0.0001
323 SKIN FISSURES 1 0.0001
324 DEATH 44 0.0001
325 NASAL CONGESTION 3 0.0001
326 DISABILITY 1 0.0001
327 HAEMATOCRIT DECREASED 1 0.0001
328 PRESCRIBED UNDERDOSE 1 0.0001
329 PREGNANCY 1 0.0000
330 ABORTION SPONTANEOUS 2 0.0000
331 ILL-DEFINED DISORDER 3 0.0000
332 PSORIATIC ARTHROPATHY 2 0.0000
333 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
334 CARDIO-RESPIRATORY ARREST 2 0.0000
335 INTENTIONAL DRUG MISUSE 1 0.0000
336 KNEE ARTHROPLASTY 1 0.0000
337 IRRITABLE BOWEL SYNDROME 1 0.0000
338 PERIPHERAL SWELLING 7 0.0000
339 FEBRILE NEUTROPENIA 3 0.0000
340 GLOSSODYNIA 1 0.0000
341 ADVERSE DRUG REACTION 4 0.0000
342 THERAPY NON-RESPONDER 2 0.0000
343 PANCREATITIS ACUTE 1 0.0000
344 NEUTROPENIA 6 0.0000
345 SHOCK 1 0.0000
346 ADVERSE EVENT 4 0.0000
347 HYPOKALAEMIA 2 0.0000
348 HYPERSENSITIVITY 8 0.0000
349 JOINT SWELLING 5 0.0000
350 LOCALISED INFECTION 1 0.0000
351 PRESYNCOPE 1 0.0000
352 LIVER INJURY 1 0.0000
353 AGGRESSION 2 0.0000
354 ABDOMINAL PAIN LOWER 1 0.0000
355 CHEST DISCOMFORT 4 0.0000
356 DRUG RESISTANCE 1 0.0000
357 DIPLOPIA 1 0.0000
358 ARTHRITIS 3 0.0000
359 JOINT STIFFNESS 1 0.0000
360 BRADYCARDIA 2 0.0000
361 EAR INFECTION 1 0.0000
362 JAUNDICE 1 0.0000
363 BLOOD BILIRUBIN INCREASED 1 0.0000
364 OEDEMA 2 0.0000
365 PALLOR 1 0.0000
366 MOOD ALTERED 1 0.0000
367 RESPIRATORY DISTRESS 1 0.0000
368 FEELING COLD 1 0.0000
369 WOUND 1 0.0000
370 ALOPECIA 7 0.0000
371 RHEUMATOID ARTHRITIS 4 0.0000
372 RED BLOOD CELL COUNT DECREASED 1 0.0000
373 BONE PAIN 2 0.0000
374 ERYTHEMA 7 0.0000
375 URINARY INCONTINENCE 1 0.0000
376 HYPOAESTHESIA 5 0.0000
377 HEPATIC FAILURE 1 0.0000
378 DISCOMFORT 2 0.0000
379 WEIGHT DECREASED 9 0.0000
380 IMPAIRED HEALING 1 0.0000
381 HEART RATE INCREASED 3 0.0000
382 VIRAL INFECTION 1 0.0000
383 URINARY RETENTION 1 0.0000
384 GAIT INABILITY 1 0.0000
385 MALAISE 13 0.0000
386 MEMORY IMPAIRMENT 4 0.0000
387 DELIRIUM 1 0.0000
388 HEART RATE DECREASED 1 0.0000
389 LYMPHADENOPATHY 1 0.0000
390 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
391 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
392 BRONCHITIS 2 0.0000
393 HEPATIC FUNCTION ABNORMAL 1 0.0000
394 BLOOD PRESSURE INCREASED 4 0.0000
395 DECREASED APPETITE 6 0.0000
396 NEUTROPHIL COUNT DECREASED 1 0.0000
397 OSTEOPOROSIS 1 0.0000
398 CARDIAC ARREST 2 0.0000
399 ROAD TRAFFIC ACCIDENT 1 0.0000
400 MENTAL DISORDER 1 0.0000
401 ANGIOEDEMA 1 0.0000
402 SKIN DISCOLOURATION 1 0.0000
403 NASOPHARYNGITIS 4 0.0000
404 ARTHRALGIA 9 0.0000
405 OROPHARYNGEAL PAIN 2 0.0000
406 COMA 1 0.0000
407 BLOOD GLUCOSE DECREASED 1 0.0000
408 CONTUSION 2 0.0000
409 DIZZINESS 10 0.0000
410 HAEMOGLOBIN DECREASED 2 0.0000
411 NERVOUSNESS 1 0.0000
412 ECZEMA 1 0.0000
413 DERMATITIS ATOPIC 1 0.0000
414 PANCREATITIS 1 0.0000
415 PLATELET COUNT DECREASED 2 0.0000
416 RASH PRURITIC 1 0.0000
417 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
418 INFLUENZA 2 0.0000
419 NECK PAIN 1 0.0000
420 BLISTER 1 0.0000
421 OXYGEN SATURATION DECREASED 1 0.0000
422 EYE PAIN 1 0.0000
423 MUSCULAR WEAKNESS 2 0.0000
424 URINARY TRACT INFECTION 3 0.0000
425 CONVULSION 1 0.0000
426 LETHARGY 1 0.0000
427 FEELING ABNORMAL 4 0.0000
428 IRRITABILITY 1 0.0000
429 MUSCLE SPASMS 3 0.0000
430 EXPOSURE DURING PREGNANCY 1 0.0000
431 RASH 7 0.0000
432 PRODUCT USE ISSUE 3 0.0000
433 INTENTIONAL OVERDOSE 1 0.0000
434 DEEP VEIN THROMBOSIS 1 0.0000
435 SWELLING FACE 1 0.0000
436 PRODUCT DOSE OMISSION 1 0.0000
437 INSOMNIA 4 0.0000
438 NEOPLASM MALIGNANT 1 0.0000
439 VISION BLURRED 2 0.0000
440 INJECTION SITE REACTION 1 0.0000
441 INJURY 1 0.0000
442 ANXIETY 4 0.0000
443 DIARRHOEA 9 0.0000
444 HALLUCINATION 1 0.0000
445 CHRONIC KIDNEY DISEASE 1 0.0000
446 BACK PAIN 3 0.0000
447 DRUG INTERACTION 2 0.0000
448 CARDIAC FAILURE 1 0.0000
449 DRUG ABUSE 1 0.0000
450 URTICARIA 2 0.0000
451 TACHYCARDIA 1 0.0000
452 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
453 CARDIAC DISORDER 1 0.0000
454 DYSPHAGIA 1 0.0000
455 SYNCOPE 1 0.0000
456 FLUSHING 1 0.0000
457 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
458 ILLNESS 1 0.0000
459 OVERDOSE 2 0.0000
460 SEIZURE 1 0.0000
461 DISEASE PROGRESSION 1 0.0000
462 VISUAL IMPAIRMENT 1 0.0000
463 INJECTION SITE ERYTHEMA 1 0.0000
464 LOSS OF CONSCIOUSNESS 1 0.0000
465 HYPERHIDROSIS 1 0.0000
466 PSORIASIS 1 0.0000
467 RENAL FAILURE 1 0.0000
468 DEHYDRATION 1 0.0000
469 DRY SKIN 1 0.0000
470 PRODUCT QUALITY ISSUE 1 0.0000
471 INFECTION 1 0.0000
472 PAIN IN EXTREMITY 2 0.0000
473 HOSPITALISATION 1 0.0000
474 PARAESTHESIA 1 0.0000
475 CONFUSIONAL STATE 1 0.0000
476 TOXICITY TO VARIOUS AGENTS 1 0.0000
477 GAIT DISTURBANCE 1 0.0000
478 PRURITUS 2 0.0000
479 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
480 WEIGHT INCREASED 1 0.0000
481 DEPRESSION 1 0.0000
482 INCORRECT DOSE ADMINISTERED 1 0.0000
483 FALL 1 0.0000